Aberrant 3′ splice sites in human disease genes: Mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization

Nucleic Acids Research

Volumn 34, Issue 16, 2006, Pages 4630-4641

  Vořechovský, Igor ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE;

3' UNTRANSLATED REGION; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; ENTROPY; EXON; GENETIC ALGORITHM; GENETIC DATABASE; GENETIC DISORDER; GENETIC MODEL; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; INTRON; NUCLEIC ACID STRUCTURE; NUCLEOTIDE SEQUENCE; ONLINE SYSTEM; PHENOTYPE; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; RNA SPLICING; ALGORITHM; BIOLOGY; COMPARATIVE STUDY; DNA BASE COMPOSITION; EVALUATION; GENETICS; INTERNET; METHODOLOGY; NUCLEIC ACID DATABASE;

ALGORITHMS; BASE COMPOSITION; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; DNA MUTATIONAL ANALYSIS; GENETIC DISEASES, INBORN; HUMANS; INTERNET; NUCLEOTIDES; RNA SPLICE SITES; SOFTWARE;

EID: 33750142512     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl535     Document Type: Article

References (124)

1. Teraoka,S.N., Telatar,M., Becker-Catania,S., Liang,T., Onengut,S., Tolun,A., Chessa,L., Sanal,Ö., Bernatowska,E., Gatti,R.A. et al. (1999) Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am. J. Hum. Genet., 64, 1617-1631.
2. Ars,E., Serra,E., Garcia,J., Kruyer,H., Gaona,A., Lazaro,C. and Estivill,X. (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum. Mol. Genet., 9, 237-247.
3. Lopez-Bigas,N., Audit,B., Ouzounis,C., Parra,G. and Guigo,R. (2005) Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett., 579, 1900-1903.
4. Krawczak,M., Reiss,J. and Cooper,D.N. (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet., 90, 41-54.
5. Nakai,K. and Sakamoto,H. (1994) Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene, 141, 171-177.
6. Cooper,T.A. and Mattox,W. (1997) The regulation of splice-site selection, and its role in human disease. Am. J. Hum. Genet., 61, 259-266.
7. Nissim-Rafinia,M. and Kerem,B. (2002) Splicing regulation as a potential genetic modifier. Trends Genet., 18, 123-127.
8. Gouya,L., Puy,H., Robreau,A.M., Bourgeois,M., Lamoril,J., Da Silva,V., Grandchamp,B. and Deybach,J.C. (2002) The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nature Genet., 30, 27-28.
9. Královiĉová,J., Gaunt,T.R., Rodriguez,S., Wood,P.J., Day,I.N.M. and Vořechovský',I. (2006) Variants in the human insulin gene that affect pre-mRNA splicing: Is-23HphI a functional single nucleotide polymorphism at IDDM2? Diabetes, 55, 260-264.
10. Roca,X., Sachidanandam,R. and Krainer,A.R. (2003) Intrinsic differences between authentic and cryptic 5′ splice sites. Nucleic Acids Res., 31, 6321-6333.
11. Královičová,J., Christensen,M.B. and Vořechovský,I. (2005) Biased exon/intron distribution of cryptic and de novo 3′ splice sites. Nucleic Acids Res., 33, 4882-4898.
12. Berglund,J.A., Chua,K., Abovich,N., Reed,R. and Rosbash,M. (1997) The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAAC. Cell, 89, 781-787.
13. Ruskin,B., Zamore,P.D. and Green,M.R. (1988) A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell, 52, 207-219.
14. Singh,R., Valcárcel,J. and Green,M.R. (1995) Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science, 268, 1173-1176.
15. Merendino,L., Guth,S., Bilbao,D., Martinez,C. and Valcárcel,J. (1999) Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3′ splice site AG. Nature, 402, 838-841.
16. Wu,S., Romfo,C.M., Nilsen,T.W. and Green,M.R. (1999) Functional recognition of the 3′ splice site AG by the splicing factor U2AF35. Nature, 402, 832-835.
17. Zorio,D.A. and Blumenthal,T. (1999) Both subunits of U2AF recognize the 3′ splice site in Caenorhabditis elegans. Nature, 402, 835-838.
18. Reed,R. (1989) The organization of 3′ splice-site sequences in mammalian introns. Genes Dev., 3, 2113-2123.
19. Smith,C.W., Chu,T.T. and Nadal-Ginard,B. (1993) Scanning and competition between AGs are involved in 3′ splice site selection in mammalian introns. Mol. Cell. Biol., 13, 4939-4952.
20. Reed,R. and Maniatis,T. (1988) The role of the mammalian branchpoint sequence in pre-mRNA splicing. Genes Dev., 2, 1268-1276.
21. Kol,G., Lev-Maor,G. and Ast,G. (2005) Human-mouse comparative analysis reveals that branch-site plasticity contributes to splicing regulation. Hum. Mol. Genet., 14, 1559-1568.
22. Gooding,C., Clark,F., Wollerton,M., Grellscheid,S.-N., Groom,H. and Smith,C.W. (2006) A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones. Genome Biol., 7, R1.
23. Shapiro,M.B. and Senapathy,P. (1987) RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res., 15, 7155-7174.
24. Senapathy,P., Shapiro,M.B. and Harris,N.L. (1990) Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome project. Methods Enzymol., 183, 252-278.
25. Brunak,S., Engelbrecht,J. and Knudsen,S. (1991) Prediction of human mRNA donor and acceptor sites from the DNA sequence. J. Mol. Biol., 220, 49-65.
26. Reese,M.G., Eeckman,F.H., Kulp,D. and Haussler,D. (1997) Improved splice site detection in Genie. J. Comput. Biol., 4, 311-323.
27. Rogan,P.K., Faux,B.M. and Schneider,T.D. (1998) Information analysis of human splice site mutations. Hum. Mutat., 12, 153-171.
28. Yeo,G. and Burge,C.B. (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol., 11, 377-394.
29. Thanaraj,T.A. (2000) Positional characterisation of false positives from computational prediction of human splice sites. Nucleic Acids Res., 28, 744-754.
30. Hiller,M., Huse,K., Szafranski,K., Jahn,N., Hampe,J., Schreiber,S., Backofen,R. and Platzer,M. (2004) Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity. Nature Genet., 36, 1255-1257.
31. Hiller,M., Huse,K., Szafranski,K., Jahn,N., Hampe,J., Schreiber,S., Backofen,R. and Platzer,M. (2006) Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing. Am. J. Hum. Genet., 78, 291-302.
32. Bendig,I., Mohr,N., Krämer,F. and Weber,B.H. (2004) Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Cancer Genet. Cytogenet., 154, 22-26.
33. Newman,P.J., Seligsohn,U., Lyman,S. and Coller,B.S. (1991) The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc. Natl Acad. Sci. USA, 88, 3160-3164.
34. Eng,L., Coutinho,G., Nahas,S., Yeo,G., Tanouye,R., Babaei,M., Dork,T., Burge,C. and Gatti,R.A. (2004) Nonclassical splicing mutations in the coding and noncoding regions of the ATM gene: Maximum entropy estimates of splice junction strengths. Hum. Mutat., 23, 67-76.
35. Chen,L.L., Sabripour,M., Wu,E.F., Prieto,V.G., Fuller,G.N. and Frazier,M.L. (2005) A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors. Oncogene, 24, 4271-4280.
36. Hovnanian,A., Rochat,A., Bodemer,C., Petit,E., Rivers,C.A., Prost,C., Fraitag,S., Christiano,A.M., Uitto,J., Lathrop,M. et al. (1997) Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation. Am. J. Hum. Genet., 61, 599-610.
37. Abramowicz,M.J., Targovnik,H.M., Varela,V., Cochaux,P., Krawiec,L., Pisarev,M.A., Propato,F.V., Juvenal,G., Chester,H.A. and Vassart,G. (1992) Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J. Clin. Invest., 90, 1200-1204.
38. Ejima,Y., Yang,L. and Sasaki,M.S. (2000) Aberrant splicing of the ATM gene associated with shortening of the intronic mononucleotide tract in human colon tumor cell lines: A novel mutation target of microsatellite instability. Int. J. Cancer, 86, 262-268.
39. Boot,R.G., Renkema,G.H., Verhoek,M., Strijland,A., Bliek,J., de Meulemeester,T.M., Mannens,M.M. and Aerts,J.M. (1998) The human chitotriosidase gene. Nature of inherited enzyme deficiency. J. Biol. Chem., 273, 25680-25685.
40. Webb,J.C., Patel,D.D., Shoulders,C.C., Knight,B.L. and Soutar,A.K. (1996) Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: A rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism. Hum. Mol. Genet., 5, 1325-1331.
41. Ohno,K., Tsujino,A., Shen,X.M., Milone,M. and Engel,A.G. (2005) Spectrum of splicing errors caused by CHRNE mutations affecting introns and intron/exon boundaries. J. Med. Genet., 42, e53.
42. Fisher,C.W., Lau,K.S., Fisher,C.R., Wynn,R.M., Cox,R.P. and Chuang,D.T. (1991) A 17-bp insertion and a Phe215Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34. Biochem. Biophys. Res. Commun., 174, 804-809.
43. Li,S.S., Tseng,H.M., Yang,T.P., Liu,C.H., Teng,S.J., Huang,H.W., Chen,L.M., Kao,H.W., Chen,J.H., Tseng,J.N. et al. (1999) Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Hum. Genet., 104, 201-204.
44. 0) leading to the activation of a cryptic splice site in intron 4. Hum. Genet., 110, 444-450.
45. Podkrajšek,K.T., Bratanič,N., Kržišnik,C. and Battelino,T. (2005) Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy patients. J. Clin. Endocrinol. Metab., 90, 4930-4935.
46. Smyth,I., Wicking,C., Wainwright,B. and Chenevix-Trench,G. (1998) The effects of splice site mutations in patients with naevoid basal cell carcinoma syndrome. Hum. Genet., 102, 598-601.
47. Cooper,D.N. and Krawczak,M. (1993) Human Gene Mutation. BIOS Scientific Publishers, Oxford.
48. Krawczak,M. and Cooper,D.N. (1996) Single base-pair substitutions in pathology and evolution: Two sides to the same coin. Hum. Mutat., 8, 23-31.
49. Parker,R. and Siliciano,P.G. (1993) Evidence for an essential non-Watson-Crick interaction between the first and last nucleotides of a nuclear pre-mRNA intron. Nature, 361, 660-662.
50. Dietrich,R.C., Fuller,J.D. and Padgett,R.A. (2005) A mutational analysis of U12-dependent splice site dinucleotides. RNA, 11, 1430-1440.
51. Deirdre,A., Scadden,J. and Smith,C.W. (1995) Interactions between the terminal bases of mammalian introns are retained in inosine-containing pre-mRNAs. EMBO J., 14, 3236-3246.
52. Gaur,R.K., Beigelman,L., Haeberli,P. and Maniatis,T. (2000) Role of adenine functional groups in the recognition of the 3′-splice-site AG during the second step of pre-mRNA splicing. Proc. Natl Acad. Sci. USA, 97, 115-120.
53. Weaving,L.S., Christodoulou,J., Williamson,S.L., Friend,K.L., McKenzie,O.L., Archer,H., Evans,J., Clarke,A., Pelka,G.J., Tam,P.P. et al. (2004) Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet., 75, 1079-1093.
54. Bonnevie-Nielsen,V., Leigh Field,L., Lu,S., Zheng,D.J., Li,M., Martensen,P.M., Nielsen,T.B., Beck-Nielsen,H., Lau,Y.L. and Pociot,F. (2005) Variation in antiviral 2′,5′-oligoadenylate synthetase (2′5′AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 Gene. Am. J. Hum. Genet., 76, 623-633.
55. Chavanas,S., Bodemer,C., Rochat,A., Hamel-Teillac,D., Ali,M., Irvine,A.D., Bonafe,J.L., Wilkinson,J., Taieb,A., Barrandon,Y. et al. (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nature Genet., 25, 141-142.
56. Yokoi,T., Shinoda,K., Ohno,I., Kato,K., Miyawaki,T. and Taniguchi,N. (1991) A 3′ splice site consensus sequence mutation in the intron 3 of the alpha-galactosidase A gene in a patient with Fabry disease. Jinrui Idengaku Zasshi, 36, 245-250.
57. Matsumura,T., Osaka,H., Sugiyama,N., Kawanishi,C., Maruyama,Y., Suzuki,K., Onishi,H., Yamada,Y., Morita,M., Aoki,M. et al. (1998) Novel acceptor splice site mutation in the invariant AG of intron 6 of alpha-galactosidase A gene, causing Fabry disease. Mutations in brief no. 146. Hum. Mutat., 11, 483.
58. Steingrimsdottir,H., Rowley,G., Dorado,G., Cole,J. and Lehmann,A.R. (1992) Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res., 20, 1201-1208.
59. Varley,J.M., Attwooll,C., White,G., McGown,G., Thorncroft,M., Kelsey,A.M., Greaves,M., Boyle,J. and Birch,J.M. (2001) Characterization of germline TP53 splicing mutations and their genetic and functional analysis. Oncogene, 20, 2647-2654.
60. Xia,K., Zheng,D., Pan,Q., Liu,Z., Xi,X., Hu,Z., Deng,H., Liu,X., Jiang,D., Deng,H. et al. (2004) A novel PRPF31 splice-site mutation in a Chinese family with autosomal dominant retinitis pigmentosa. Mol. Vis., 10, 361-365.
61. Pasmooij,A.M., Pas,H.H., Deviaene,F.C., Nijenhuis,M. and Jonkman,M.F. (2005) Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am. J. Hum. Genet., 77, 727-740.
62. Schimpf,S., Schaich,S. and Wissinger,B. (2005) Activation of cryptic splice sites is a frequent splicing defect mechanism caused by mutations in exon and intron sequences of the OPA1 gene. Hum. Genet., 118, 767-771.
63. Rickard,S.J. and Wilson,L.C. (2003) Analysis of GNAS1 and overlapping transcripts identifies the parental origin of mutations in patients with sporadic Albright hereditary osteodystrophy and reveals a model system in which to observe the effects of splicing mutations on translated and untranslated messenger RNA. Am. J. Hum. Genet., 72, 961-974.
64. Schloesser,M., Hofferbert,S., Bartz,U., Lutze,G., Lammle,B. and Engel,W. (1995) The novel acceptor splice site mutation 11396(G→A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients. Hum. Mol. Genet., 4, 1235-1237.
65. Weber,Y., Steinberger,D., Deuschl,G., Benecke,R. and Muller,U. (1997) Two previously unrecognized splicing mutations of GCH1 in Dopa-responsive dystonia: Exon skipping and one base insertion. Neurogenetics, 1, 125-127.
66. Hartikainen,J.M., Pirskanen,M.M., Arffman,A.H., Ristonmaa,U.K. and Mannermaa,A.J. (2000) A Finnish BRCA1 exon 12 4216-2nt A to G splice acceptor site mutation causes aberrant splicing and frameshift, leading to protein truncation. Hum. Mutat., 15, 120.
67. O'Neill,J.P., Rogan,P.K., Cariello,N. and Nicklas,J.A. (1998) Mutations that alter RNA splicing of the human HPRT gene: A review of the spectrum. Mutat. Res., 411, 179-214.
68. Nichols,K.E., Houseknecht,M.D., Godmilow,L., Bunin,G., Shields,C., Meadows,A. and Ganguly,A. (2005) Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene. Hum. Mutat., 25, 566-574.
69. Satokata,I., Tanaka,K., Miura,N., Miyamoto,I., Satoh,Y., Kondo,S. and Okada,Y. (1990) Characterization of a splicing mutation in group A xeroderma pigmentosum. Proc. Natl Acad. Sci. USA, 87, 9908-9912.
70. Rizzo,W.B., Carney,G. and Lin,Z. (1999) The molecular basis of Sjögren-Larsson syndrome: Mutation analysis of the fatty aldehyde dehydrogenase gene. Am. J. Hum. Genet., 65, 1547-1560.
71. Beghini,A., Castorina,P., Roversi,G., Modiano,P. and Larizza,L. (2003) RNA processing defects of the helicase gene RECQL4 in a compound heterozygous Rothmund-Thomson patient. Am J. Med. Genet. A, 120, 395-399.
72. Bromidge,T., Lowe,C., Prentice,A. and Johnson,S. (2000) p53 intronic point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukaemia. Br. J. Haematol., 111, 223-229.
73. Jin,Y., Dietz,H.C., Montgomery,R.A., Bell,W.R., McIntosh,I., Coller,B. and Bray,P.F. (1996) Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. J. Clin. Invest., 98, 1745-1754.
74. Villa,A., Notarangelo,L.D., Di Santo,J.P., Macchi,P.P., Strina,D., Frattini,A., Lucchini,F., Patrosso,C.M., Giliani,S., Mantuano,E. et al. (1994) Organization of the human CD40L gene: Implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc. Natl Acad. Sci. USA, 91, 2110-2114.
75. Burge,C.B. (1998) Modeling dependencies in pre-mRNA splicing signals. In Salzberg,S. L., Searls,D. B. and Kasif,S. (eds), Computational methods in molecular biology. Elsevier Science, Amsterdam, pp. 129-164.
76. Hollins,C., Zorio,D.A., MacMorris,M. and Blumenthal,T. (2005) U2AF binding selects for the high conservation of the C. elegans 3′ splice site. RNA, 11, 248-253.
77. Valcárcel,J., Gaur,R.K., Singh,R. and Green,M.R. (1996) Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA. Erratum in: Science, 274, 21.
78. Shen,H., Kan,J.L. and Green,M.R. (2004) Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly. Mol. Cell, 13, 367-376.
79. Shen,H. and Green,M.R. (2006) RS domains contact splicing signals and promote splicing by a common mechanism in yeast through humans. Genes Dev., 20, 1755-1765.
80. Liu,Z., Luyten,I., Bottomley,M.J., Messias,A.C., Houngninou-Molango,S., Sprangers,R., Zanier,K., Krämer,A. and Sattler,M. (2001) Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science, 294, 1098-1102.
81. Královičová,J., Houngninou-Molango,S., Krämer,A. and Vořechovský,I. (2004) Branch sites haplotypes that control alternative splicing. Hum. Mol. Genet., 13, 3189-3202.
82. Zhuang,Y. and Weiner,A.M. (1989) A compensatory base change in human U2 snRNA can suppress a branch site mutation. Genes Dev., 3, 1545-1552.
83. Wu,J. and Manley,J.L. (1989) Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing. Genes Dev., 3, 1553-1561.
84. Mount,S.M. (1982) A catalogue of splice junction sequences. Nucleic Acids Res., 10, 459-472.
85. Saeys,Y., Degroeve,S., Aeyels,D., Rouze,P. and Van de Peer,Y. (2004) Feature selection for splice site prediction: A new method using EDA-based feature ranking. BMC Bioinformatics, 5, 64.
86. Yeo,G., Hoon,S., Venkatesh,B. and Burge,C.B. (2004) Variation in sequence and organization of splicing regulatory elements in vertebrate genes. Proc. Natl Acad. Sci. USA, 101, 15000-15005.
87. Banerjee,H., Rahn,A., Davis,W. and Singh,R. (2003) Sex lethal and U2 small nuclear ribonucleoprotein auxiliary factor (U2AF65) recognize polypyrimidine tracts using multiple modes of binding. RNA, 9, 88-99.
88. Kent,O.A., Reayi,A., Foong,L., Chilibeck,K.A. and MacMillan,A.M. (2003) Structuring of the 3′ splice site by U2AF65. J. Biol. Chem., 278, 50572-50577.
89. Roscigno,R.F., Weiner,M. and Garcia-Blanco,M.A. (1993) A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem., 268, 11222-11229.
90. Singh,R., Banerjee,H. and Green,M.R. (2000) Differential recognition of the polypyrimidine-tract by the general splicing factor U2AF65 and the splicing repressor sex-lethal. RNA, 6, 901-911.
91. Smith,C.W., Porro,E.B., Patton,J.G. and Nadal-Ginard,B. (1989) Scanning from an independently specified branch point defines the 30 splice site of mammalian introns. Nature, 342, 243-247.
92. Sickmier,E.A., Frato,K.E., Shen,H., Paranawithana,S.R., Green,M.R. and Kielkopf,C.L. (2006) Structural basis for polypyrimidine tract recognition by the essential pre-mRNA splicing factor U2AF65. Mol. Cell, 23, 49-59.
93. Urban,Z., Michels,V.V., Thibodeau,S.N., Donis-Keller,H., Csiszar,K. and Boyd,C.D. (1999) Supravalvular aortic stenosis: A splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts. Hum. Genet., 104, 135-142.
94. Janssen,R.J., Wevers,R.A., Haussler,M., Luyten,J.A., Steenbergen-Spanjers,G.C., Hoffmann,G.F., Nagatsu,T. and Van den Heuvel,L.P. (2000) A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann. Hum. Genet., 64, 375-382.
95. Fujimaru,M., Tanaka,A., Choeh,K., Wakamatsu,N., Sakuraba,H. and Isshiki,G. (1998) Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3′-splice site selection and cause Sandhoff disease. Hum. Genet., 103, 462-469.
96. Lucarini,L., Giusti,B., Zhang,R.Z., Pan,T.C., Jimenez-Mallebrera,C., Mercuri,E., Muntoni,F., Pepe,G. and Chu,M.L. (2005) A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy. Hum. Genet., 117, 460-466.
97. Mayer,K., Ballhausen,W., Leistner,W. and Rott,H. (2000) Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences. Biochim. Biophys. Acta, 1502, 495-507.
98. Thomas,P.M., Cote,G.J., Wohllk,N., Haddad,B., Mathew,P.M., Rabl,W., Aguilar-Bryan,L., Gagel,R.F. and Bryan,J. (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science, 268, 426-429.
99. Chua,K. and Reed,R. (2001) An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing. Mol. Cell. Biol., 21, 1509-1514.
100. Marchetti,C., Patriarca,P., Solero,G.P., Baralle,F.E. and Romano,M. (2004) Genetic studies on myeloperoxidase deficiency in Italy. Jpn. J. Infect. Dis., 57, S10-12.
101. Cladaras,C., Hadzopoulou-Cladaras,M., Felber,B.K., Pavlakis,G. and Zannis,V.I. (1987) The molecular basis of a familial apoE deficiency. An acceptor splice site mutation in the third intron of the deficient apoE gene. J. Biol. Chem., 262, 2310-2315.
102. Antonarakis,S.E., Irkin,S.H., Cheng,T.C., Scott,A.F., Sexton,J.P., Trusko,S.P., Charache,S. and Kazazian,H.H.,Jr (1984) beta-Thalassemia in American Blacks: Novel mutations in the 'TATA' box and an acceptor splice site. Proc. Natl Acad. Sci. USA, 81, 1154-1158.
103. Atweh,G.F., Anagnou,N.P., Shearin,J., Forget,B.G. and Kaufman,R.E. (1985) Beta-thalassemia resulting from a single nucleotide substitution in an acceptor splice site. Nucleic Acids Res., 13, 777-790.
104. Wong,C., Antonarakis,S.E., Goff,S.C., Orkin,S.H., Forget,B.G., Nathan,D.G., Giardina,P.J. and Kazazian,H.H.,Jr (1989) Beta-thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the beta-globin gene. Blood, 73, 914-918.
105. Otterness,D.M., Szumlanski,C.L., Wood,T.C. and Weinshilboum,R.M. (1998) Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity. J. Clin. Invest., 101, 1036-1044.
106. Wassif,C.A., Maslen,C., Kachilele-Linjewile,S., Lin,D., Linck,L.M., Connor,W.E., Steiner,R.D. and Porter,F.D. (1998) Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am. J. Hum. Genet., 63, 55-62.
107. Bulman,M.P., Harries,L.W., Hansen,T., Shepherd,M., Kelly,W.F., Hattersley,A.T. and Ellard,S. (2002) Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young. Diabetologia, 45, 1463-1467.
108. Darling,T.N., Yee,C., Koh,B., McGrath,J.A., Bauer,J.W., Uitto,J., Hintner,H. and Yancey,K.B. (1998) Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa. J. Invest. Dermatol., 110, 165-169.
109. Shah,A.B., Chernov,I., Zhang,H.T., Ross,B.M., Das,K., Lutsenko,S., Parano,E., Pavone,L., Evgrafov,O., Ivanova-Smolenskaya,I.A. et al. (1997) Identification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses. Am. J. Hum. Genet., 61, 317-328.
110. Bouma,P., Cabral,W.A., Cole,W.G. and Marini,J.C. (2001) COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II. J. Biol. Chem., 276, 13356-13364.
111. Verselis,S.J., Rheinwald,J.G., Fraumeni,J.F.,Jr and Li,F.P. (2000) Novel p53 splice site mutations in three families with Li-Fraumeni syndrome. Oncogene, 19, 4230-4235.
112. Vockley,J., Rogan,P.K., Anderson,B.D., Willard,J., Seelan,R.S., Smith,D.I. and Liu,W. (2000) Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. Am. J. Hum. Genet., 66, 356-367.
113. Mardy,S., Miura,Y., Endo,F., Matsuda,I., Sztriha,L., Frossard,P., Moosa,A., Ismail,E.A., Macaya,A., Andria,G. et al. (1999) Congenital insensitivity to pain with anhidrosis: Novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am. J. Hum. Genet., 64, 1570-1579.
114. Teng,Y.N., Wang,T.R., Hwu,W.L., Lin,S.P. and Lee-Chen,G.J. (2000) Identification and characterization of -3c-g acceptor splice site mutation in human alpha-L-iduronidase associated with mucopolysaccharidosis type IH/S. Clin. Genet., 57, 131-136.
115. Hamed,S., Sutherland-Smith,A., Gorospe,J., Kendrick-Jones,J. and Hoffman,E. (2005) DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy. Clin. Genet., 68, 69-79.
116. Bunge,S., Steglich,C., Zuther,C., Beck,M., Morris,C.P., Schwinger,E., Schinzel,A., Hopwood,J.J. and Gal,A. (1993) Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Hum. Mol. Genet., 2, 1871-1875.
117. Dominski,Z. and Kole,R. (1991) Selection of splice sites in pre-mRNAs with short internal exons. Mol. Cell. Biol., 11, 6075-6083.
118. Morgan,N.V., Tipping,A.J., Joenje,H. and Mathew,C.G. (1999) High frequency of large intragenic deletions in the Fanconi anemia group A gene. Am. J. Hum. Genet., 65, 1330-1341.
119. Messiaen,L.M., Callens,T., Mortier,G., Beysen,D., Vandenbroucke,I., Van Roy,N., Speleman,F. and Paepe,A.D. (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum. Mutat., 15, 541-555.
120. Maquat,L.E. (2005) Nonsense-mediated mRNA decay in mammals. J. Cell Sci., 118, 1773-1776.
121. Resch,A., Xing,Y., Alekseyenko,A., Modrek,B. and Lee,C. (2004) Evidence for a subpopulation of conserved alternative splicing events under selection pressure for protein reading frame preservation. Nucleic Acids Res., 32, 1261-1269.
122. Gudikote,J.P., Imam,J.S., Garcia,R.F. and Wilkinson,M.F. (2005) RNA splicing promotes translation and RNA surveillance. Nature Struct. Mol. Biol., 12, 801-809.
123. Hebsgaard,S.M., Korning,P.G., Tolstrup,N., Engelbrecht,J., Rouze,P. and Brunak,S. (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res., 24, 3439-3452.
124. Wang,M. and Marin,A. (2006) Characterization and prediction of alternative splice sites. Gene, 366, 219-227. Nucleic Acids Research, 2006, Vol. 34, No. 16 4641